Decision: Favourable

Decisions Table

Study Title:

MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation

  • NREC Code:

    21-NREC-MD-004

  • Decision:

    Favourable

  • Meeting Date:

    24/06/2021

  • Study Type:

    MD application

  • Principal Investigator:

    Prof James Loughman

  • PI Institution:

    Technological University Dublin

  • Sponsor:

    Dopavision GmbH

Scroll to Top